These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10678359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR, Williams CR, Buchsbaum DJ, Gillespie GY.
    Cancer Res; 2002 Feb 01; 62(3):773-80. PubMed ID: 11830532
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F, Sawada H, Hirao T, Fujii H, Hamada H, Nakano H.
    Cancer Gene Ther; 2000 Jul 01; 7(7):1015-22. PubMed ID: 10917204
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C, Nemunaitis J.
    Hum Gene Ther; 2001 Aug 10; 12(12):1594-6. PubMed ID: 11529249
    [Abstract] [Full Text] [Related]

  • 7. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F, Sawada H, Fujii H, Hirao T, Ueno M, Hamada H, Nakano H.
    J Exp Clin Cancer Res; 2000 Mar 10; 19(1):75-80. PubMed ID: 10840940
    [Abstract] [Full Text] [Related]

  • 8. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P, Regulier E, Kintz J, Leroy P, Poitevin Y, Exinger F, Jund R, Mehtali M.
    Cancer Res; 2000 Jul 15; 60(14):3813-22. PubMed ID: 10919655
    [Abstract] [Full Text] [Related]

  • 9. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N, Worgall S, Hackett NR, Crystal RG.
    Gene Ther; 1998 Apr 15; 5(4):507-13. PubMed ID: 9614575
    [Abstract] [Full Text] [Related]

  • 10. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Adachi Y, Tamiya T, Ichikawa T, Terada K, Ono Y, Matsumoto K, Furuta T, Hamada H, Ohmoto T.
    Hum Gene Ther; 2000 Jan 01; 11(1):77-89. PubMed ID: 10646641
    [Abstract] [Full Text] [Related]

  • 11. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW, Lee H, Kim E, Lee Y, Chung SS, Kim JH.
    Neurosurgery; 2000 Oct 01; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
    Cao X, Ju DW, Tao Q, Wang J, Wan T, Wang BM, Zhang W, Hamada H.
    Gene Ther; 1998 Aug 01; 5(8):1130-6. PubMed ID: 10326037
    [Abstract] [Full Text] [Related]

  • 13. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA, Chen MJ, Green NK, Burton A, Anderson D, Mautner V, Searle PF, Kerr DJ.
    Gene Ther; 2001 Oct 01; 8(20):1547-54. PubMed ID: 11704815
    [Abstract] [Full Text] [Related]

  • 14. Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.
    Bentires-Alj M, Hellin AC, Lechanteur C, Princen F, Lopez M, Fillet G, Gielen J, Merville MP, Bours V.
    Cancer Gene Ther; 2000 Jan 01; 7(1):20-6. PubMed ID: 10678352
    [Abstract] [Full Text] [Related]

  • 15. Effects of CD/5-FC suicide gene therapy system on human malignant glioma cells in vitro.
    Lv SQ, Yang H, He JQ, Wang B, Yoshimura I, Liu YS.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May 01; 35(5):430-4. PubMed ID: 12766803
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
    Kosaka H, Ichikawa T, Kurozumi K, Kambara H, Inoue S, Maruo T, Nakamura K, Hamada H, Date I.
    Cancer Gene Ther; 2012 Aug 01; 19(8):572-8. PubMed ID: 22744211
    [Abstract] [Full Text] [Related]

  • 17. [Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo].
    Yao Y, Peng Z, Wang H, Li Q, Liu S.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Apr 01; 37(4):195-7. PubMed ID: 12133407
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R, Cohen S, Atkinson G, Hall SJ.
    J Urol; 2000 Dec 01; 164(6):2173-7. PubMed ID: 11061950
    [Abstract] [Full Text] [Related]

  • 19. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN, Mauceri HJ, Wayne JD, Hallahan DE, Kufe DW, Weichselbaum RR.
    Cancer Res; 1997 Oct 01; 57(19):4205-9. PubMed ID: 9331076
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.